Daig, Hermenita .

HRN: 26-74-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
AMPICILLIN 1GM (VIAL)
05/30/2025
06/02/2025
IV
2 G
Q6
PROM
Waiting Final Action 
05/31/2025
CEFUROXIME 500MG (TAB)
05/31/2025
06/06/2025
PO
500mg
BID X 7 Days
PROM; RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: